Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
17.26 USD | +4.83% | +10.48% | +15.07% |
May. 02 | NovoCure Shares Steady After Reporting Narrower Q1 Loss, Higher Revenue | MT |
May. 02 | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.07% | 1.77B | |
+73.48% | 12.41B | |
-18.22% | 8.23B | |
+2.68% | 6.46B | |
+15.76% | 5.5B | |
-4.95% | 5.33B | |
+40.80% | 5.1B | |
-18.32% | 4.05B | |
-28.53% | 2.54B | |
+7.56% | 1.99B |
- Stock Market
- Equities
- NVCR Stock
- News NovoCure Limited
- Piper Sandler Upgrades NovoCure to Overweight From Neutral, Price Target is $45